Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Signal Transduction and Targeted Therapy|October 7, 2020
The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case seriesHao Zeng, Dongfang Wang, Jingmin Nie, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2022
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical TrialYao Lin, Shuai Yue, Yang Yang, et al.Signal Transduction and Targeted Therapy|September 4, 2020
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19Xiangyu Chen, Zhiwei Pan, Shuai Yue, et al.JAMA Network Open|February 16, 2022
Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled TrialHongyi Wang, Zixin Wang, Xiaojie Huang, et al.Journal of Medical Virology|April 21, 2025
A Visual Nomogram Survival Prediction Model in Acquired Immune Deficiency Syndrome (AIDS)-Related Diffuse Large B-Cell LymphomaTao Yang, Haike Lei, Jun Li, et al.The Lancet Regional Health. Western Pacific|March 30, 2026
Virologic, immunologic, and metabolic outcomes and mortality in people with HIV on bictegravir/emtricitabine/tenofovir alafenamide fumarate versus dolutegravir-based antiretroviral therapies: a retrospective multicenter cohort study in ChinaXinsheng Wu, Ping Ma, Lianguo Ruan, et al.Frontiers in Psychiatry|September 11, 2018
The Double Burdens of Mental Health Among AIDS Patients With Fully Successful Immune Restoration: A Cross-Sectional Study of Anxiety and Depression in ChinaXiaojie Huang, Kathrine Meyers, Xinchao Liu, et al.The Lancet Regional Health. Western Pacific|August 7, 2023
Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96Bin Su, Guiju Gao, Min Wang, et al.Nature|August 9, 2016
Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infectionRan He, Shiyue Hou, Cheng Liu, et al.Journal of Pharmaceutical Analysis|February 23, 2026
Large-scale evaluation of HIV-1 DNA drug resistance testing as a robust tool for clinical decision-making: A nationwide study in ChinaCaihong Wu, Limin Zhang, Zhong Chen, et al.Pageof 15